User profiles for Edward W. Cowen
Edward CowenNational Institutes of Health Verified email at mail.nih.gov Cited by 20790 |
[HTML][HTML] National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working …
…, J Chien, D Przepiorka, D Couriel, EW Cowen… - Biology of blood and …, 2005 - Elsevier
This consensus document is intended to serve 3 functions. First, it standardizes the criteria
for diagnosis of chronic graft-versus-host disease (GVHD). Second, it proposes a new clinical …
for diagnosis of chronic graft-versus-host disease (GVHD). Second, it proposes a new clinical …
[HTML][HTML] National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and …
…, M Arora, KM Williams, D Wolff, EW Cowen… - Biology of Blood and …, 2015 - Elsevier
The 2005 National Institutes of Health (NIH) Consensus Conference proposed new criteria
for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD). The …
for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD). The …
[HTML][HTML] Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
…, J Wheless, J Wu, TN Darling, EW Cowen… - Pediatric …, 2013 - Elsevier
Background Tuberous sclerosis complex is highly variable in clinical presentation and
findings. Disease manifestations continue to develop over the lifetime of an affected individual. …
findings. Disease manifestations continue to develop over the lifetime of an affected individual. …
[HTML][HTML] Activated STING in a vascular and pulmonary syndrome
Background The study of autoinflammatory diseases has uncovered mechanisms underlying
cytokine dysregulation and inflammation. Methods We analyzed the DNA of an index …
cytokine dysregulation and inflammation. Methods We analyzed the DNA of an index …
[HTML][HTML] An autoinflammatory disease with deficiency of the interleukin-1–receptor antagonist
…, R Laxer, U Tedgård, EW Cowen… - … England Journal of …, 2009 - Mass Medical Soc
Background Autoinflammatory diseases manifest inflammation without evidence of infection,
high-titer autoantibodies, or autoreactive T cells. We report a disorder caused by mutations …
high-titer autoantibodies, or autoreactive T cells. We report a disorder caused by mutations …
[HTML][HTML] Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
…, J Wheless, J Wu, TN Darling, EW Cowen… - Pediatric …, 2013 - Elsevier
Background Tuberous sclerosis complex is a genetic disorder affecting every organ system,
but disease manifestations vary significantly among affected individuals. The diverse and …
but disease manifestations vary significantly among affected individuals. The diverse and …
[HTML][HTML] Early-onset stroke and vasculopathy associated with mutations in ADA2
…, A Negro, WL Tsai, EW Cowen, W Pei… - … England Journal of …, 2014 - Mass Medical Soc
Background We observed a syndrome of intermittent fevers, early-onset lacunar strokes and
other neurovascular manifestations, livedoid rash, hepatosplenomegaly, and systemic …
other neurovascular manifestations, livedoid rash, hepatosplenomegaly, and systemic …
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity
Haploinsufficiency of the hematopoietic transcription factor GATA2 underlies monocytopenia
and mycobacterial infections; dendritic cell, monocyte, B, and natural killer (NK) lymphoid …
and mycobacterial infections; dendritic cell, monocyte, B, and natural killer (NK) lymphoid …
[HTML][HTML] Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations
Background Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …
[HTML][HTML] Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials …
The lack of standardized criteria for quantitative measurement of therapeutic response in
clinical trials poses a major obstacle for the development of new agents in chronic graft-versus-…
clinical trials poses a major obstacle for the development of new agents in chronic graft-versus-…